cyclo(prolylglycyl) has been researched along with Stroke in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 2 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hyodo, K; Kaneko, H; Namihira, M; Numata, N; Yamamoto, S | 1 |
| Anderson, T; Dalrymple-Alford, J; Guan, J; Kang, D; Li, F; Pitcher, T; Shorten, P; Singh-Mallah, G | 1 |
| Miltyk, W; Misiura, M | 1 |
| Barber, PA; Fan, D; Guan, J; Harris, P; Krishnamurthi, R | 1 |
2 review(s) available for cyclo(prolylglycyl) and Stroke
| Article | Year |
|---|---|
Cyclic Glycine-Proline (cGP) Normalises Insulin-Like Growth Factor-1 (IGF-1) Function: Clinical Significance in the Ageing Brain and in Age-Related Neurological Conditions.
Topics: Aged; Aging; Brain; Clinical Relevance; Humans; Insulin-Like Growth Factor Binding Protein 3; Insulin-Like Growth Factor I; Nervous System Diseases; Parkinson Disease; Stroke | 2023 |
Proline-containing peptides-New insight and implications: A Review.
Topics: Dipeptides; Gastric Mucosa; Humans; Inflammatory Bowel Diseases; Neutrophils; Oligopeptides; Peptides; Peptides, Cyclic; Proline; Signal Transduction; Stroke; Wound Healing | 2019 |
2 other study(ies) available for cyclo(prolylglycyl) and Stroke
| Article | Year |
|---|---|
Oral administration of cyclic glycyl-proline facilitates task learning in a rat stroke model.
Topics: Administration, Oral; Animals; Disease Models, Animal; Dose-Response Relationship, Drug; Learning; Male; Neurogenesis; Neuronal Plasticity; Neuroprotective Agents; Peptides, Cyclic; Rats; Stroke | 2022 |
Plasma cyclic glycine proline/IGF-1 ratio predicts clinical outcome and recovery in stroke patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Brain Ischemia; Female; Glycine; Humans; Insulin-Like Growth Factor I; Male; Middle Aged; Peptides, Cyclic; Plasma; Proline; Stroke; Young Adult | 2019 |